Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania

Table 4

Adjusted OR after multivariate analysis for predictors of treatment outcome of cure.

Characteristics	Cured	Other treatment categories	aOR (95% CI)	p-value
	N (%)	N (%)
Cavitary lesions on CXR (N=279)
Yes	45(70.3)	19(29.7)	1.89(1.27-2.81)	0.002
No	143(66.5)	72(33.5)
BMI
Below 18.5	9(60.0)	6(40.0)	0.59(0.39-0.88)	0.044
Above or equal 18.5	199(62.8)	118(37.2)
Residence
Dar	105(65.2)	56(34.8)	1.03(0.58-1.81)	0.922
Other	103(60.2)	68(39.8)
Positive baseline sputum culture (N=253)
Yes	105(68.2)	49(31.8)	1.55(0.79-3.01)	0.200
No	62(62.6)	37(37.4)
HIV status (N=208)
Yes	71(61.2)	45(38.8)	1.03(0.57-1.86)	0.933
No	137(63.4)	79(36.6)
Positive baseline sputum smear (N=253)
Yes	105 (68.2)	49 (31.8)	0.62(0.30-1.29)	0.203
No	62 (62.6)	37 (37.4)
Isoniazid (N=141)
Resistant	87(66.9)	43(33.1)	1.03(0.47-2.26)	0.948
susceptible	7(63.6)	4(36.4)
Rifampicin (N=207)
Resistant	128(63.4)	74(36.6)	0.77(0.37-1.59)	0.479
Susceptible	4(80.0)	1(20)
Streptomycin (N=114)
Resistant	51(63.8)	29(36.3)	4.67(1.53-14.32)	0.007
susceptible	28(82.4)	6(17.6)
Ethambutol (N=110)
Resistant	50(68.5)	23(31.5)	0.34(0.12-0.96)	0.041
susceptible	25(67.6)	12(32.4)